|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Rubius Therapeutics, Inc. (RUBY) |
|
|
$0.06 0.00 (0.00%) as of 4:30 Fri 12/29
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
89,770,000 |
| Market
Cap: |
5.12(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.01615 - $0.057 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Rubius Therapeutics is a clinical-stage biopharmaceutical company that is biologically engineering red blood cells to develop a class of cellular medicines called Red Cell Therapeutics for the treatment of cancer and autoimmune diseases. Co.'s platform, RED PLATFORM, biologically engineers and cultures allogeneic red blood cell therapies that enable multiple applications, or modalities. Co.'s immune stimulation for the treatment of cancer includes RTX-240, which is designed to stimulate the immune system by activating and expanding both NK and CD8+ memory T cells to generate an anti-tumor response; and RTX-224, which is designed as an immune agonist of both adaptive and innate responses.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
38,281 |
| Total Sell Value |
$0 |
$0 |
$0 |
$11,362 |
| Total People Sold |
0 |
0 |
0 |
3 |
| Total Sell Transactions |
0 |
0 |
0 |
6 |
| End Date |
2024-02-29 |
2023-11-28 |
2023-05-30 |
2022-05-30 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Langer Robert |
Director |
– • – |
2019-04-15 |
4 |
AS |
$17.57 |
$131,799 |
D/D |
(7,500) |
0 |
|
- |
|
| Langer Robert |
Director |
– • – |
2019-04-15 |
4 |
OE |
$0.15 |
$1,125 |
D/D |
7,500 |
7,500 |
|
- |
|
| Nissen Torben Straight |
President |
• – – |
2019-04-08 |
4 |
AS |
$20.00 |
$42,000 |
D/D |
(2,100) |
1,845,304 |
|
- |
|
| Nissen Torben Straight |
President |
• – – |
2019-04-05 |
4 |
AS |
$20.00 |
$241,920 |
D/D |
(12,096) |
1,847,404 |
|
- |
|
| Nissen Torben Straight |
President |
• – – |
2019-04-03 |
4 |
AS |
$20.00 |
$10,000 |
D/D |
(500) |
1,859,500 |
|
- |
|
| Carpenter Christopher L. |
Chief Medical Officer |
• – – |
2019-03-15 |
4 |
AS |
$15.84 |
$760,114 |
D/D |
(48,000) |
34,843 |
|
- |
|
| Carpenter Christopher L. |
Chief Medical Officer |
• – – |
2019-03-15 |
4 |
OE |
$2.87 |
$137,760 |
D/D |
48,000 |
82,843 |
|
- |
|
| Carpenter Christopher L. |
Chief Medical Officer |
• – – |
2019-01-22 |
4 |
OE |
$2.87 |
$99,999 |
D/D |
34,843 |
34,843 |
|
- |
|
| Langer Robert |
Director |
– • – |
2019-01-14 |
4 |
AS |
$14.59 |
$109,444 |
D/D |
(7,500) |
0 |
|
- |
|
| Langer Robert |
Director |
– • – |
2019-01-14 |
4 |
OE |
$0.15 |
$1,125 |
D/D |
7,500 |
7,500 |
|
- |
|
| Sohn Catherine A. |
Director |
– • – |
2018-07-20 |
4 |
B |
$23.00 |
$57,500 |
D/D |
2,500 |
2,500 |
2.39 |
- |
|
| Pomerantz Roger |
Director |
– • – |
2018-07-20 |
4 |
B |
$23.00 |
$2,300 |
D/D |
100 |
100 |
2.31 |
- |
|
| Cuss Francis M |
Director |
– • – |
2018-07-20 |
4 |
B |
$23.00 |
$230,000 |
D/D |
10,000 |
10,000 |
2.39 |
- |
|
| Kania Edwin M Jr |
10% Owner |
– – • |
2018-07-20 |
4 |
A |
$0.00 |
$0 |
I/I |
33,296,526 |
2,563,703 |
|
- |
|
| Symonds Jonathan |
Director |
– • – |
2018-07-20 |
4 |
B |
$23.00 |
$575,000 |
D/D |
25,000 |
25,000 |
2.39 |
- |
|
65 Records found
|
|
Page 3 of 3 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
